Differential kinetics of human cytomegalovirus load and antibody responses in primary infection of the immunocompetent and immunocompromised host

Journal of General Virology

Volumn 96, Issue 2, 2015, Pages 360-369

  Gerna, Giuseppe ^a   Lilleri, Daniele ^a,b   Fornara, Chiara ^a   Bruno, Francesca ^a   Gabanti, Elisa ^a   Cane, Ilaria ^a   Furione, Milena ^a   Grazia Revello, M ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; IMMUNOGLOBULIN G ANTIBODY; VIRUS GLYCOPROTEIN; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; VIRUS DNA; VIRUS PROTEIN;

ADULT; ANTIBODY RESPONSE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; FIBROBLAST; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED PATIENT; MALE; PRIMARY INFECTION; PRIORITY JOURNAL; VIRUS LOAD; ANTIBODY PRODUCTION; BLOOD; COMPARATIVE STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; GRAFT RECIPIENT; IMMUNOLOGY; ISOLATION AND PURIFICATION; PREGNANCY; TIME; VIROLOGY; YOUNG ADULT;

HUMAN HERPESVIRUS 5;

ADULT; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN G; MALE; PREGNANCY; TIME FACTORS; TRANSPLANT RECIPIENTS; VIRAL LOAD; VIRAL PROTEINS; YOUNG ADULT;

EID: 84921751818     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.070441-0     Document Type: Article

References (26)

1. Cui, X., Meza, B. P., Adler, S. P. & McVoy, M. A. (2008). Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection. Vaccine 26, 5760-5766.
2. Fouts, A. E., Chan, P., Stephan, J. P., Vandlen, R. & Feierbach, B. (2012). Antibodies against the gH/gL/UL128/UL130/UL131 complex comprise the majority of the anti-cytomegalovirus (anti-CMV) neutralizing antibody response in CMV hyperimmune globulin. J Virol 86, 7444-7447.
3. Furione, M., Rognoni, V., Cabano, E. & Baldanti, F. (2012). Kinetics of human cytomegalovirus (HCMV) DNAemia in transplanted patients expressed in international units as determined with the Abbott RealTime CMV assay and an in-house assay. J Clin Virol 55, 317-322.
4. Furione, M., Rognoni, V., Sarasini, A., Zavattoni, M., Lilleri, D., Gerna, G. & Revello, M. G. (2013). Slow increase in IgG avidity correlates with prevention of human cytomegalovirus transmission to the fetus. J Med Virol 85, 1960-1967.
5. Genini, E., Percivalle, E., Sarasini, A., Revello, M. G., Baldanti, F. & Gerna, G. (2011). Serum antibody response to the gH/gL/pUL128-131 five-protein complex of human cytomegalovirus (HCMV) in primary and reactivated HCMV infections. J Clin Virol 52, 113-118.
6. Gerna, G., Percivalle, E., Lilleri, D., Lozza, L., Fornara, C., Hahn, G., Baldanti, F. & Revello, M. G. (2005). Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8+ T cells. J Gen Virol 86, 275-284.
7. Gerna, G., Vitulo, P., Rovida, F., Lilleri, D., Pellegrini, C., Oggionni, T., Campanini, G., Baldanti, F. & Revello, M. G. (2006). Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients. J Med Virol 78, 408-416.
8. Gerna, G., Sarasini, A., Patrone, M., Percivalle, E., Fiorina, L., Campanini, G., Gallina, A., Baldanti, F. & Revello, M. G. (2008). Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection. J Gen Virol 89, 853-865.
9. Griffiths, P. D., Stanton, A., McCarrell, E., Smith, C., Osman, M., Harber, M., Davenport, A., Jones, G., Wheeler, D. C. & other authors (2011). Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial. Lancet 377, 1256-1263.
10. Hahn, G., Revello, M. G., Patrone, M., Percivalle, E., Campanini, G., Sarasini, A., Wagner, M., Gallina, A., Milanesi, G. & other authors (2004). Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J Virol 78, 10023-10033.
11. He, J., Tsai, L. M., Leong, Y. A., Hu, X., Ma, C. S., Chevalier, N., Sun, X., Vandenberg, K., Rockman, S. & other authors (2013). Circulating precursor CCR7loPD-1hi CXCR5+ CD4+ T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. Immunity 39, 770-781.
12. Lilleri, D., Zelini, P., Fornara, C., Comolli, G., Revello, M. G. & Gerna, G. (2009). Human cytomegalovirus-specific CD4+ and CD8+ T cell responses in primary infection of the immunocompetent and the immunocompromised host. Clin Immunol 131, 395-403.
13. Lilleri, D., Kabanova, A., Lanzavecchia, A. & Gerna, G. (2012). Antibodies against neutralization epitopes of human cytomegalovirus gH/gL/pUL128-130-131 complex and virus spreading may correlate with virus control in vivo. J Clin Immunol 32, 1324-1331.
14. Lilleri, D., Kabanova, A., Revello, M. G., Percivalle, E., Sarasini, A., Genini, E., Sallusto, F., Lanzavecchia, A., Corti, D. & Gerna, G. (2013). Fetal human cytomegalovirus transmission correlates with delayedmaternal antibodies to gH/gL/pUL128-130-131 complex during primary infection. PLoS ONE 8, e59863.
15. Lozza, L., Lilleri, D., Percivalle, E., Fornara, C., Comolli, G., Revello, M. G. & Gerna, G. (2005). Simultaneous quantification of human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells by a novel method using monocyte-derived HCMV-infected immature dendritic cells. Eur J Immunol 35, 1795-1804.
16. Macagno, A., Bernasconi, N. L., Vanzetta, F., Dander, E., Sarasini, A., Revello, M. G., Gerna, G., Sallusto, F. & Lanzavecchia, A. (2010). Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex. J Virol 84, 1005-1013.
17. Pass, R. F., Zhang, C., Evans, A., Simpson, T., Andrews, W., Huang, M. L., Corey, L., Hill, J., Davis, E. & other authors (2009). Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med 360, 1191-1199.
18. Pötzsch, S., Spindler, N., Wiegers, A. K., Fisch, T., Rücker, P., Sticht, H., Grieb, N., Baroti, T., Weisel, F. & other authors (2011). B cell repertoire analysis identifies new antigenic domains on glycoprotein B of human cytomegalovirus which are target of neutralizing antibodies. PLoS Pathog 7, e1002172.
19. Revello, M. G. & Gerna, G. (2002). Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 15, 680-715.
20. Revello, M. G. & Gerna, G. (2010). Human cytomegalovirus tropism for endothelial/epithelial cells: scientific background and clinical implications. Rev Med Virol 20, 136-155.
21. Revello, M. G., Genini, E., Gorini, G., Klersy, C., Piralla, A. & Gerna, G. (2010). Comparative evaluation of eight commercial human cytomegalovirus IgG avidity assays. J Clin Virol 48, 255-259.
22. Revello, M. G., Fabbri, E., Furione, M., Zavattoni, M., Lilleri, D., Tassis, B., Quarenghi, A., Cena, C., Arossa, A. & other authors (2011). Role of prenatal diagnosis and counseling in the management of 735 pregnancies complicated by primary human cytomegalovirus infection: a 20-year experience. J Clin Virol 50, 303-307.
23. Ryckman, B. J., Rainish, B. L., Chase, M. C., Borton, J. A., Nelson, J. A., Jarvis, M. A. & Johnson, D. C. (2008). Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells. J Virol 82, 60-70.
24. Sallusto, F. & Lanzavecchia, A. (1994). Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179, 1109-1118.
25. Wang, D. & Shenk, T. (2005). Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc Natl Acad Sci U S A 102, 18153-18158.
26. Zhou, M., Yu, Q., Wechsler, A. & Ryckman, B. J. (2013). Comparative analysis of gO isoforms reveals that strains of human cytomegalovirus differ in the ratio of gH/gL/gO and gH/gL/UL128-131 in the virion envelope. J Virol 87, 9680-9690.